ImmunoVec, .

ImmunoVec, .ImmunoVec, .

ImmunoVec, .

Stealth modeStealth Mode

Develops in vivo therapies to precisely engineer any targeted cell type within the human body.

Website
DR 8Active12
Rate
Advertise here

About

ImmunoVec develops in vivo therapies that precisely engineer targeted cell types within the human body. Their core technology utilizes cell type and cell state-specific transcriptional control elements to regulate the expression of DNA-encodable payloads, ensuring precise expression across various viral and non-viral delivery platforms. This enables the development of cell type-specific therapies for therapeutic interventions.
HEADCOUNT
12
DOMAIN RATING
8
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does ImmunoVec, . do?

ImmunoVec develops in vivo therapies that precisely engineer targeted cell types within the human body. Their core technology utilizes cell type and cell state-specific transcriptional control elements to regulate the expression of DNA-encodable payloads, ensuring precise expression across various viral and non-viral delivery platforms. This enables the development of cell type-specific therapies for therapeutic interventions.

What industry does ImmunoVec, . operate in?

ImmunoVec, . operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Therapeutics.

How many employees does ImmunoVec, . have?

ImmunoVec, . has approximately 12 people on record.

What is ImmunoVec, .'s revenue?

StartupHub estimates ImmunoVec, .'s annual revenue at $1.2M (range $680K to $4.9M, 64% confidence), based on comparable companies in the sector.